(S)-3-Cyclohexylmorpholine is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and cardiovascular disorders. Additionally, it serves as a building block in organic synthesis for creating complex molecules with potential therapeutic applications. Its unique cyclohexyl and morpholine moieties contribute to its role in enhancing the pharmacokinetic properties of drug candidates, such as solubility and stability.